Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Oral tofacitinib successfully treated total body hair loss in one patient.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Different types of stem cells with unique roles exist in blood, skin, and intestines, and this variety is important for tissue repair.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Gut flora changes could potentially indicate depression, but more research is needed.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

FOXN1 gene variants cause low T cells and immune issues from birth.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

CBD can either promote or inhibit hair growth depending on the concentration used.

Lipid nanoparticles improve drug delivery through the skin, offering stability, controlled release, and better compatibility with skin.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Human hair follicles have a scent receptor that can influence hair growth.